Back
MoonLake Immunotherapeutics Vs. Novartis AG Industry Stock Comparison
Buy
71
MLTX
MoonLake Immunotherapeutics
Last Price:
53.61
Seasonality Move:
36.4%
Buy
62
NVS
Novartis AG
Last Price:
104.97
Seasonality Move:
1.51%
Buy
71
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy, Sell or Hold?
- The current MoonLake Immunotherapeutics [MLTX] share price is $51.86. The Score for MLTX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- MLTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $103.85. The Score for NVS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MLTX Stock Price Chart
What is MoonLake Immunotherapeutics's stock price today?
-
The MoonLake Immunotherapeutics share price today is $51.86
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $103.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MLTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 56.35 | Buy |
| Chaikin Money Flow: | 215543 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.92 - 51.28) | Buy |
| Bollinger Bands (100): | (44.56 - 51.18) | Buy |
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.82 | Sell |
| Relative Strength Index (14 RSI): | 29.93 | Sell |
| Chaikin Money Flow: | 1255993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.1 - 113.22) | Sell |
| Bollinger Bands (100): | (108.03 - 117.01) | Sell |
MLTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.47 | Buy |
| 20-day SMA: | 49.43 | Buy |
| 50-day SMA: | 50.11 | Buy |
| 200-day SMA: | 46.92 | Buy |
| 8-day EMA: | 50.37 | Buy |
| 20-day EMA: | 49.9 | Buy |
| 50-day EMA: | 49.25 | Buy |
| 200-day EMA: | 47.25 | Buy |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.56 | Buy |
| 20-day SMA: | 107.1 | Sell |
| 50-day SMA: | 112.08 | Sell |
| 200-day SMA: | 106.39 | Sell |
| 8-day EMA: | 104.06 | Sell |
| 20-day EMA: | 106.69 | Sell |
| 50-day EMA: | 110.1 | Sell |
| 200-day EMA: | 107.77 | Sell |
MoonLake Immunotherapeutics Earnings Growth & MLTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.72 per share.
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
MoonLake Immunotherapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||